For those with eczema, dealing with flare-ups entails chronic discomfort and constant worry about the next time they have to endure itching and pain that comes from this condition.

This long-lasting condition does not just make skin itchy, patchy and scaly. It can also be accompanied by asthma or hay fever. While no cure has been found for atopic dermatitis, patients have been advised to avoid triggers that worsen their conditions.

In recent years, there has been development in the treatment of eczema, including a prescription medication by the brand name of Dupixent. This subcutaneously deployed prescription medication is used to treat:

  • Patients with moderate to severe eczema above 12 years of age.
  • Patients with moderate to sever asthma.
  • Patients with chronic rhinosinusitis with nasal polyps.

Dupixent has been found to be effective in treating eczema. In a clinical trial for teenagers with moderate to severe eczema, 24% saw clearer skin, while 37% of people had less itching within a 16-week period. In adults, clinical trials showed that almost half had a 75% improvement in their skin. Between 36% to 39% of people had clear or almost-clear skin at the end of a 16-week period.

While Dupixent does not entirely remove the risks of future flare-ups, it has helped those suffering from eczema to better manage their conditions by experiencing less itching and reduction of rashes for a better quality of life.

New Specialists, Same Old S Aesthetics Clinic Prices

If you’re suffering form eczema or eczema-related issues, we’re here to help. With our new dermatology specialists at S Aesthetics Clinic, we stand ready to help you with your skin conditions at the prices you are already familiar with. Walk-in, call us at 6235 0338, or email us at hello@saestheticsclinic.com and start your journey to the skin you desire and deserve.

You May Also Like:

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *